Sunday, February 11, 2018 7:14:18 AM
As most of you are aware, the latest newsletter stated that Warwick Mills could not produce the sample shootpacks because of the "small quantity of silk thread" that was provided. The thread was then sent to a "textile research facility".
Here is the exact quote from the newsletter:
I started thinking about this yesterday and I realized that this brings up another potential major issue.
It has been stated a few times that the cocoons from KBLB's transgenic worms are smaller than normal. This seems to be a problem for the silk industry. The smaller cocoons led to KBLB missing their 1st deadline for the sample shootpacks (Apr 2017), when the reeler was blamed because they couldn't work with the smaller cocoons.
But now it seems that Warwick also had issues because of the smaller cocoons (since smaller cocoons will produce smaller reels of fiber). So the smaller cocoons seem to be the reason for KBLB missing their 2nd deadline for the sample shootpacks as well (Dec 2017).
So it seems that the silk industry in general is used to using "normal" size reels from "normal" size cocoons.
So the question is, "How will KBLB mass produce fiber when the industry isn't setup for small cocoons?"
KBLB's current solution for the issue that Warwick had is to turn to a "research facility". But I doubt that a "research facility" will be able to mass produce. It might be able to create a few sample shootpacks, but that is about it.
One of KBLB's latest PRs (from 19 Jan 2018) even states that they are trying to create larger cocoons:
So it looks like they have acknowledged the issue and are trying to figure out how to solve the problem, but they are only at the beginning stages.
Once again, this tells me that KBLB is nowhere close to commercialization. They are still a research lab trying to figure out how to get there.
Recent KBLB News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM